Patents Assigned to UNIVERSITÉ PARIS—SACLAY
  • Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-, pro- or synbiotics) for improving the efficacy of a cancer treatment
    Patent number: 10646521
    Abstract: The present invention provides methods for determining if a patient is likely to benefit from a cancer treatment, by determining if said patient has a gut dysbiosis with an over representation of certain bacterial species. The present invention also provides probiotic strains to improve the efficacy of a cancer treatment, especially chemotherapy, in patients in need thereof.
    Type: Grant
    Filed: November 21, 2014
    Date of Patent: May 12, 2020
    Assignees: INSTITUT GUSTAVE ROUSSY, UNIVERSITÉ PARIS—SACLAY, INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE, INSTITUT DE LA RECHERCHE AGRONOMIQUE
    Inventors: Laurence Zitvogel, Ivo Gomperts Boneca, Patricia Lepage, Sophie Viaud, Romain Daillere